Invega sustenna and Glossodynia - a phase IV clinical study of FDA data

Summary:

Glossodynia is reported only by a few people who take Invega Sustenna.

The phase IV clinical study analyzes which people take Invega sustenna and have Glossodynia. It is created by eHealthMe based on reports of 20,322 people who have side effects while taking Invega sustenna from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 03, 2022

20,322 people reported to have side effects when taking Invega sustenna.
Among them, 3 people (0.01%) have Glossodynia.


What is Invega sustenna?

Invega sustenna has active ingredients of paliperidone palmitate. It is often used in schizoaffective disorder. eHealthMe is studying from 20,414 Invega sustenna users for its effectiveness, alternative drugs and more.

What is Glossodynia?

Glossodynia (a burning or painful sensation in the tongue) is found to be associated with 1,611 drugs and 1,094 conditions by eHealthMe.

Number of Invega sustenna and Glossodynia reports submitted per year:

Could Invega sustenna cause Glossodynia?

Gender of people who have Glossodynia when taking Invega sustenna *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Glossodynia when taking Invega sustenna *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 33.33 %
  • 40-49: 0.0 %
  • 50-59: 66.67 %
  • 60+: 0.0 %

Common drugs people take besides Invega sustenna *:

  1. Nicorette: 1 person, 33.33%

Common side effects people have besides Glossodynia *:

  1. Dyskinesia (abnormality or impairment of voluntary movement): 2 people, 66.67%
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 33.33%
  3. Oral Pain: 1 person, 33.33%
  4. Hypersensitivity: 1 person, 33.33%

Common conditions people have *:

  1. Bipolar Disorder (mood disorder): 2 people, 66.67%

* Approximation only. Some reports may have incomplete information.

Do you take Invega sustenna and have Glossodynia?

Check whether Glossodynia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Glossodynia and when was it recovered:

Expand to all the drugs that have ingredients of paliperidone palmitate:

Alternative drugs to, pros and cons of Invega sustenna:

Common Invega sustenna side effects:

Browse all side effects of Invega sustenna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Glossodynia treatments and more:

COVID vaccines that are related to Glossodynia:

Common drugs associated with Glossodynia:

All the drugs that are associated with Glossodynia:

Common conditions associated with Glossodynia:

All the conditions that are associated with Glossodynia:

How the study uses the data?

The study uses data from the FDA. It is based on paliperidone palmitate (the active ingredients of Invega sustenna) and Invega sustenna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: